2019 internationellt biofarmaceutiskt 4.0 toppmötet kommer att hållas i mars 21-22, fokus på automationshantering av AI-tekniken, one-time
use system in monoclonal antibody, polyklonal akropp, Adc, Pd 1, Bil – T, hot areas such as gene therapy applications and development and production
outsourcing contract (CDMO (cdmo)) affärsmodell, and aims to create top summit of biological medicine industry, the official interpretation of the policy and one
of the hottest investment opportunities.